倡导妊娠早期巨细胞病毒母体血清学筛查:若不知去向,终将迷途
本文主张在计划妊娠或妊娠早期(11-14周)开展巨细胞病毒(CMV)母体血清学筛查。血清学是唯一能识别高达50%先天性CMV感染的筛查工具,在11-14周约0.5%人群可检出IgM和IgG阳性及低IgG亲和力。伐昔洛韦可安全用于胎儿早期并降低70%垂直传播,应尽早实施。
要点
- 血清学筛查可在11-14周识别约0.5%人群的IgM/IgG阳性及低亲和力,覆盖高达50%先天感染。
- 年轻经产血清学阴性女性计划二胎时风险极高,应在计划或诊断妊娠时及孕早期末筛查。
- 伐昔洛韦孕早期安全使用可降低70%垂直传播,母体感染后应尽早启用。
核心结论
- 应倡导在计划妊娠或妊娠早期(最好11-14周)提供CMV母体血清学筛查。
- 血清学筛查是唯一能识别高达50%先天性CMV感染的可靠工具。
- 伐昔洛韦可安全用于胎儿早期并降低70%垂直传播,应尽早实施。
研究设计与样本
- 本文为论述性文章,未报告系统检索方法或样本量。
主要发现
- 血清学阴性孕妇的前瞻性先天感染风险是免疫女性的4倍。
- 在11-14周约0.5%人群可检出IgM和IgG阳性及低IgG亲和力,可识别高达50%先天感染。
- 伐昔洛韦降低70%垂直传播;胎儿影像对出生时症状和先天残疾的阴性预测值为95%-99%。
关键数值与推荐
- 推荐在计划妊娠或诊断妊娠时及孕早期末(11-14周)进行血清学筛查。
- 若只能采一次样本,11-14周就诊是最实用的折中时机。
- 母体感染后应尽早使用伐昔洛韦以降低垂直传播。
- 羊水PCR检测病毒DNA是可靠诊断方法,绒毛膜绒毛取样可提前2个月达到相同性能。
临床怎么用
- 在高收入和中等收入国家,可通过实验室和胎儿医学网络开展诊断与治疗。
- 对计划或确诊妊娠的血清学阴性女性,尤其年轻经产者,应提供孕早期血清学筛查。
- 确诊胎儿感染后可行胎儿影像评估,阴性预测值高;产前治疗可减少出生时及2岁时症状。
局限性
- 本文为论述性文章,未报告原始研究数据或系统评价。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Congenital cytomegalovirus infection is an important health problem for the individual and the community. Although it could derive from both primary and nonprimary maternal infection, the prospective risk of congenital infection in seronegative pregnant women is 4 times than that of immune women. Maternal serology is the only reliable screening tool in pregnancy that would identify up to 50% of all congenital cytomegalovirus infections, by yielding positive immunoglobulin M and immunoglobulin G and low immunoglobulin G avidity in approximately 0.5% of the population at 11 to 14 weeks. The exceptionally high risk for young parous seronegative women planning a second pregnancy makes a compelling case for offering serologic screening as soon as pregnancy is planned or diagnosed and by the end of the first trimester. The 11- to 14-week consultation has become an unmissable one worldwide and would represent the most practical compromise if only 1 sample can be taken. Valaciclovir that can be safely used in the early fetal period decreases vertical transmission by 70% and should be implemented as early as possible after maternal infection. Facilities for diagnosis and treatment are available in high- and middle-income countries through laboratory and fetal medicine networks. Amniocentesis with amplification of the viral DNA by polymerase chain reaction in the amniotic fluid is a reliable diagnostic test but chorionic villi sampled by chorionic villus sampling could achieve the same performance 2 months earlier. Fetal imaging of a known infected fetus yields a negative predictive value on symptoms at birth and congenital handicap of between 95% and 99%, and prenatal treatment of infected fetuses decreases the occurrence of symptoms at birth and at 2 years of age.
引用
- Ville Y. Advocating for cytomegalovirus maternal serologic screening in the first trimester of pregnancy: if you do not know where you are going, you will wind up somewhere else. Am J Obstet Gynecol MFM. 2021. PMID: 33762222. doi:10.1016/j.ajogmf.2021.100356
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。